Skip to Content

Essilorluxottica EL

Morningstar Rating
€208.60 +2.20 (1.07%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

EL is trading at a 75% premium.
Price
€208.60
Fair Value
€629.78
Uncertainty
Medium
1-Star Price
€447.47
5-Star Price
€578.83
Economic Moat
Phbks
Capital Allocation
Xnglhtnpl

Bulls Say, Bears Say

Bulls

EssilorLuxottica is the leader in the fragmented eyewear industry, more than twice the size of the next-biggest player, which allows manufacturing at scale.

Bears

As a serial acquirer EssilorLuxottica faces operational risk when integrating targets.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EL is a good fit for your portfolio.

News

Trading Information

Previous Close Price
€206.40
Day Range
€205.10209.60
52-Week Range
€159.68212.40
Bid/Ask
€205.40 / €209.80
Market Cap
€96.38 Bil
Volume/Avg
559,308 / 402,344

Key Statistics

Price/Earnings (Normalized)
30.46
Price/Sales
3.78
Dividend Yield (Trailing)
1.89%
Dividend Yield (Forward)
1.89%
Total Yield
2.14%

Company Profile

EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest player in their respective fields and command over 15% of the fragmented global eyewear market. The company has a broad geographical presence, with around 36% of sales in Europe, 47% in North America, and the rest in Asia and Latin America.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
200,000

Competitors

Valuation

Metric
EL
COO
Price/Earnings (Normalized)
30.4629.44
Price/Book Value
2.522.53
Price/Sales
3.785.33
Price/Cash Flow
18.0622.61
Price/Earnings
EL
COO

Financial Strength

Metric
EL
COO
Quick Ratio
0.630.81
Current Ratio
1.001.86
Interest Coverage
15.904.77
Quick Ratio
EL
COO

Profitability

Metric
EL
COO
Return on Assets (Normalized)
4.87%2.49%
Return on Equity (Normalized)
7.79%3.88%
Return on Invested Capital (Normalized)
6.03%3.63%
Return on Assets
EL
COO
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncPxkrldxjlpRmyjv$140.6 Bil
BDX
Becton Dickinson & CoPzmhvwrlTrqzxn$68.3 Bil
ALC
Alcon IncNcdtddcHgwjbm$43.6 Bil
RMD
ResMed IncMnzgjqvdZqskjny$32.1 Bil
CLPBY
Coloplast A/S ADRGpqgfszvcHvcn$27.9 Bil
WST
West Pharmaceutical Services IncZwycknbqhYnbv$26.0 Bil
COO
The Cooper Companies IncKrjmrthhwLnyzvr$19.3 Bil
BAX
Baxter International IncXthymszlHrzndg$18.1 Bil
HOLX
Hologic IncWpqbzpqjyWvwtm$17.5 Bil
TFX
Teleflex IncBkyhFfqfd$10.3 Bil

Sponsor Center